Weight Management

---

Here at Evolve MedSpa, we provide multiple treatment options for weight loss, one of them is Semaglutide. Our providers use Semaglutide by itself or in combination with other medications to help our patients lose weight.

• Semaglutide is the first once-weekly medication in its class that’s FDA-approved to help with chronic weight management. It works best when used in combination with a healthy diet and exercise.

Semaglutide is know commercially as Wegovy or Ozempic.

• The largest clinical trial showed that adults taking semaglutide lost an average of almost 15% of their initial body weight — about 12% more than those who didn’t take the medication. Adolescent clinical trials showed an average weight loss of 16%

Long-term changes in diet and activity are an important part of maintaining weight loss after stopping Semaglutide.

Semaglutide is an injectable glucagon-like peptide-1 (GLP-1) agonist that’s administered once weekly. It was originally approved in 2017 — at a lower dose under the brand name Ozempic — to help control blood sugar in Type 2 diabetes. People taking Ozempic for blood sugar control also tend to lose weight as an additional benefit.

Now, semaglutide (under the brand name Wegovy) is FDA approved for weight loss.

Semaglutide is also approved for chronic weight management in adolescents ages 12 and older.

Semaglutide should be used in combination with lifestyle changes, including a healthy diet and exercise.

GLP-1 is an incretin hormone that plays a role in your appetite and digestion. Incretins — hormones released by your digestive tract — are sent out by your body after you’ve eaten a meal. They help lower your blood sugar by triggering insulin release and blocking sugar production. They also slow down how quickly food leaves your stomach (called gastric emptying).

The result of these actions causes you to feel full — lowering your appetite and causing you to lose weight. Medications like GLP-1 agonists are referred to as incretin mimetics since they “mimic” these effects.

Semaglutide is given as once a week injection. It can be given at any time of day, and you can take it with or without food.

Semaglutide is typically injected just under the skin (subcutaneously) in your abdomen, upper arm, or thigh.

Since semaglutide slows down how quickly food leaves your stomach, you may experience side effects like nausea and vomiting.

Once you get started on the medication, our doctors will modify your dose weekly depending on the weight loss and the side effects to help you get the best results.

Gastrointestinal (GI) side effects tend to happen most frequently when taking this medication. The most common are nausea, diarrhea, and vomiting. You may experience these effects more strongly with the higher doses.

Additional common side effects can include:

• Constipation
• Stomach pain
• Headache
• Fatigue
• Indigestion
• Dizziness
• Bloating
• Burping

Tirzepatide is an injectable dual-action medication that activates two key hormone receptors: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism helps regulate blood sugar levels, reduce appetite, and improve metabolism.

Originally approved under the brand name Mounjaro for Type 2 diabetes management, Tirzepatide has since been approved under Zepbound for chronic weight management in adults. It is typically used alongside a healthy diet and exercise plan.

Tirzepatide mimics the effects of two natural hormones — GLP-1 and GIP — that help control appetite and blood sugar.
These hormones slow digestion, promote fullness, and reduce hunger signals in the brain, resulting in fewer calories consumed and gradual, consistent weight loss.

This dual-hormone approach makes Tirzepatide particularly effective for both weight management and metabolic health.

Tirzepatide is administered once weekly as a subcutaneous injection, typically in the abdomen, upper arm, or thigh.
It can be taken at any time of day, with or without food.

Our providers start patients on a low dose to minimize side effects, then gradually increase the dosage based on tolerance, results, and individual goals. This customized approach ensures the safest and most effective outcome for each patient.

Like Semaglutide, Tirzepatide can cause gastrointestinal side effects, especially when beginning treatment or increasing dosage. The most common are nausea, diarrhea, and vomiting.

Other possible side effects include:
• Constipation
• Stomach pain or bloating
• Headache
• Fatigue
• Indigestion
• Dizziness
• Belching

These effects typically lessen as your body adjusts to the medication. Our providers will guide you through dose adjustments and supportive care to help minimize discomfort and maintain your progress.